Radiofrequency-based Systems Account for Whopping 75% Revenue Share of Renal Denervation Technologies: Fact.MR Study

Emergence of Micro-Infusion Technology, Continuous Research & Development Initiatives for Enhancements of Healthcare Systems, And Rising Adoption of Advanced Renal Denervation Systems Are Factors Driving Market Growth

United States, Rockville MD, Aug. 11, 2022 (GLOBE NEWSWIRE) -- As per in-depth industry analysis by Fact.MR, a market research and competitive intelligence provider, the global renal denervation technologies market is anticipated to surge ahead at a stellar CAGR of 40% from 2022 to 2026.

Increasing prevalence of lifestyle disorders such as hypertension due to a rise in sedentary and stressful lifestyles, alcoholic and tobacco use, poor eating habits, and escalating senior population are driving market expansion. The benefits of renal denervation technologies such as speedy recovery, security, convenience, and cost-effectiveness are acting as significant growth-inducing factors.

For Critical Insights on Renal Denervation Technologies Market, Request a Sample Report

Catheter-based procedures to remove renal nerves have demonstrated significant outcomes. Additionally, catheter-based techniques seem to be less risky for patients and make the denervation of particular nerves easier. Factors projected to propel demand growth for renal denervation technologies are increased prevalence of hypertension with ineffective anti-hypertensive medications, long-lasting effect of renal denervation, and constant advancements in renal denervation devices.

Due to benefits such as improved safety, shorter treatment times, permanent effects, and an increase in uncontrolled and treatment-resistant hypertension in the urban population as a result of changing lifestyle habits, the market for renal denervation technologies and related processes is set to surge at a rapid pace over the coming years.

What’s Shaping Renal Denervation Technologies Market Growth?

“Increase in Funding for R&D Initiatives for Treatment of Renal Disorders”

Demand for renal denervation procedures is anticipated to be aided by various authorities and government organizations increasing funding for R&D initiatives for renovascular hypertension treatment. Additionally, advancements in renal denervation devices could propel the industry.

One of the key factors increasing the adoption of the renal denervation method is the number of new skills it introduces. The drawbacks of high frequency-based renal denervation systems can be overcome by an ultrasonic RDN device. Without making direct touch with the tissue, high-frequency sound waves and ultrasonic energy assist in the removal of nerves.

This lessens the risk of renal artery injury. This quality makes this method preferred by a sizable number of patients worldwide. The effectiveness of these strategies will also be greatly enhanced by incorporating technology into these kinds of health practices and paving the opportunities in the renal denervation industry.

To learn more about Renal Denervation Technologies Market, you can get in touch with our Analyst at

Key Segments Covered in the Renal Denervation Technologies Industry Survey

  • By Product:

    • Symplicity
    • Vessix
    • EnligHTN
    • Paradise
    • Iberis
    • Others
  • By Technology:

    • Radiofrequency-based
    • Ultrasound-based
    • Micro-infusion-based

  • By End User:

    • Hospitals
    • Specialty Clinics
    • Research & Academic Institutes
    • Ambulatory Care Centers
  • By Region:

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Winning Strategy

Renal denervation device manufacturing companies are taking steps to increase their presence in the global market, such as innovative product releases and collaborations. Leading businesses are making significant investments to differentiate themselves from one another and flourish in the current market environment. Market players are also encouraged to use creative marketing techniques to promote the use of renal denervation devices.

For instance,

  • In 2021, The Paradise Ultrasound Renal Denervation System was introduced by ReCor Medical. The special product is anticipated to simplify patient diagnosis of uncontrolled hypertension throughout Germany.

Get Customization on Renal Denervation Technologies Market Report for Specific Research Solutions

Key players in the Renal Denervation Technologies Market

  • Medtronic
  • Boston Scientific Corp.
  • Symple Surgical, Inc.
  • Terumo Corporation
  • Ablative Solutions, Inc.
  • Abbott Laboratories
  • Renal Dynamics Limited
  • Mercator MedSystems, Inc.
  • ReCor Medical, Inc.

Key Takeaways from Renal Denervation Technologies Market Study

  • Global renal denervation technologies market to reach valuation of US$ 720 million by 2026.
  • Market in Germany set to expand at CAGR of 33% over forecast period.
  • Demand for ultrasound-based technologies projected to rise at 37% CAGR through 2026.
  • Market in Canada expected to rise at CAGR of 36% from 2022 to 2026.

Explore Fact.MR's Coverage on the Healthcare Domain-

Recombinant Protein Market – Proteins resulting from expression of recombinant DNA (rDNA), within living cells, are known as recombinant proteins. rDNAs are DNA molecules that are formed by laboratory procedures of genetic recombination, to bring genetic material together from multiple sources.

Gas Chromatography Market - Gas chromatography (GC) is used for analysis and separation of compounds, which are capable of vaporizing without undergoing decomposition. GC is used for testing purity of substances, separating the components in a mixture. Gas chromatography is also being used for preparing pure compounds from mixtures, and identifying the compounds.

Diabetic Food Market - Diabetic Food Market Share & Trends Analysis, By Nature (Organic, Conventional), By Type (Bakery Products, Dairy Products, Others), By Distribution Channel (Direct, Indirect) & By Region Forecast - Global Market Insights 2018 to 2028

Urodynamic Devices Market - The primary objective of an urodynamic test is understanding disorders/problems occurring in lower urinary tract by duplication of symptoms. Urodynamic study also help in determination of the causes of bladder dysfunction, formulating an appropriate course for the treatment.

Antibodies Market - The global demand for antibodies is expected to remain moderate in the forthcoming years. Increasing prevalence of chronic ailments such as autoimmune diseases, cancer, diabetes and others is encouraging manufacturers to step up investments in R&D activities pertaining to antibodies.

Amniocentesis Needle Market - Demand for the amniocentesis needles is expected to gain momentum attributed to growing need for removing excessive amniotic fluid from around the baby. Excessive amniotic fluid during pregnancy leads to increasing risks of complication.

Prefilled Syringes Market - The global market for prefilled syringes is expected to grow at a value CAGR of nearly 10% from 2021 to 2031. Short-term forecast appears equally lucrative, registering a growth rate of 9.6% until 2026.

Actigraphy Sensors & PSG Devices Market - The actigraphy sensor and PSG devices market is witnessing positive growth with the frontrunners accounting for nearly two-third of the total revenue in the market. Frontrunners in the actigraphy sensor and PSG devices market, including Koninklijke Philips N.V., Fitbit, Inc., Garmin Ltd., and ResMed Inc., have maintained a strong foothold in the market.

Lithotripsy Devices Market - The lithotripsy devices market is anticipated to surpass US$ 2 Billion by 2031- trailing at a CAGR of over 5%. The market is largely driven by the increased prevalence of urolithiasis, an increase in the number of extracorporeal shock waves lithotripsy operations, technical developments, and rising awareness.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter